US 12286402
Compounds and their use for the treatment of alpha1-antitrypsin deficiency
granted A61PA61P1/16A61P11/00
Quick answer
US patent 12286402 (Compounds and their use for the treatment of alpha1-antitrypsin deficiency) held by CENTESSA PHARMACEUTICALS (UK) LIMITED expires Mon Apr 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CENTESSA PHARMACEUTICALS (UK) LIMITED
- Grant date
- Tue Apr 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61P, A61P1/16, A61P11/00